Effect of HIT Components on the Development of Breast Cancer Cells

Effect of HIT Components on the Development of Breast Cancer Cells

Cancer cells circulating in blood vessels activate platelets, forming a cancer cell encircling platelet cloak which facilitates cancer metastasis. Heparin (H) is frequently used as an anticoagulant in cancer patients but up to 5% of patients have a side effect, heparin-induced thrombocytopenia (HIT)...

Full description

Bibliographic Details
Main Authors:	Li-Yu Chen, Gurunath Apte, Annerose Lindenbauer, Marion Frant, Thi-Huong Nguyen
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Life
Subjects:	platelet factor 4 monoclonal antibodies heparin thrombocytopenia breast cancer cells
Online Access:	https://www.mdpi.com/2075-1729/11/8/832

Similar Items

Heparin-induced thrombocytopenia after MitraClip: A case report
by: Özge Çetinarslan, et al.
Published: (2018-03-01)

The frequency of heparin-induced thrombocytopenia in Taiwanese patients undergoing cardiopulmonary bypass surgery
by: Yeu-Chin Chen, et al.
Published: (2015-10-01)

The Role of Single-Molecule Force Spectroscopy in Unraveling Typical and Autoimmune Heparin-induced Thrombocytopenia
by: Van-Chien Bui, et al.
Published: (2018-04-01)

Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia
by: Caroline Vayne, et al.
Published: (2020-07-01)

Autoimmune Heparin-Induced Thrombocytopenia after Transcatheter Aortic Valve Implantation: Successful Treatment with Adjunct High-Dose Intravenous Immunoglobulin
by: Tamam Bakchoul, et al.
Published: (2019-04-01)

Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion
by: Jonathan S. Williams, et al.
Published: (2018-01-01)

Long-term anti-PF4 persistence in autoimmune heparin-induced thrombocytopenia: A glimpse into the natural history of vaccine-induced immune thrombotic thrombocytopenia
by: Guillaume Roberge, et al.
Published: (2021-12-01)

High‐dose IVIG plus cangrelor platelet “anesthesia” during urgent heparin‐CPB in a patient with recent SRA‐negative HIT‐thrombosis with persisting platelet‐activating antibodies
by: Andreas Koster, et al.
Published: (2020-08-01)

Heparin‐induced thrombocytopenia in end‐stage renal disease: Reliability of the PF4‐heparin ELISA
by: Julie Kelly, et al.
Published: (2021-07-01)

Does ‘heparin-induced thrombocytopenia’ hit our minds?
by: Arun R. Thangavel, et al.
Published: (2016-08-01)

Hats Off to HIT: A Case Report
by: Akhwand Shakeel Ahmad, et al.
Published: (2012-05-01)

Heparin- induced thrombocytopenia (HIT): a case report of CABG patient
by: Alireza Jahangirifard, et al.
Published: (2016-08-01)

Argatroban for an alternative anticoagulant in HIT during ECMO
by: Alain Rougé, et al.
Published: (2017-06-01)

Platelet Activation in Heparin-Induced Thrombocytopenia is Followed by Platelet Death via Complex Apoptotic and Non-Apoptotic Pathways
by: Elmira R. Mordakhanova, et al.
Published: (2020-04-01)

The Inhibitory Effect of Protamine on Platelets is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents
by: Joanna Miklosz, et al.
Published: (2019-09-01)

Temporality of heparin-induced antibodies: a retrospective study in outpatients undergoing hemodialysis on unfractionated heparin
by: Satish Maharaj, et al.
Published: (2018-09-01)

Platelet-Derived Microparticles Bearing PF4 and Anti-GAGS Immunoglobulins in Patients with Sepsis
by: Maria Teresa Sartori, et al.
Published: (2020-08-01)

Diagnostics of thrombocytopenias
by: A V Mazurov, et al.
Published: (2018-07-01)

Acute non‐heparin‐induced thrombocytopenia during hemodiafiltration in a patient with multiple myeloma
by: Makiko Morita, et al.
Published: (2019-04-01)

Heparin induced thrombocytopenia
by: Yunus Nazlı, et al.
Published: (2014-03-01)

Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature
by: Daniel E. Ezekwudo, et al.
Published: (2017-07-01)

Heparininduced thrombocytopenia in patients with venous thromboembolic complications – clinical cases and review of the literature
by: N. Yu. Semigolovskii, et al.
Published: (2018-04-01)

Current Perspectives on Diagnostic Assays and Anti-PF4 Antibodies for the Diagnosis of Heparin-Induced Thrombocytopenia
by: Sahu KK, et al.
Published: (2020-08-01)

Trombocitopenia y trombosis inducida por heparina Heparin-induced thrombocytopenia and thrombosis
by: Rosario Ruiz Domínguez, et al.
Published: (2010-03-01)

Heparin-Induced Thrombocytopenia: A Review of New Concepts in Pathogenesis, Diagnosis, and Management
by: Matteo Marchetti, et al.
Published: (2021-02-01)

An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management Recommendations
by: Amin Islam, et al.
Published: (2021-08-01)

Post-Transfusion Purpura: Current Perspectives
by: Hawkins J, et al.
Published: (2019-12-01)

Current perspectives on fetal and neonatal alloimmune thrombocytopenia – increasing clinical concerns and new treatment opportunities
by: Tiller H, et al.
Published: (2017-04-01)

The importance of antibody dependent cell-mediated cytotoxicity (ADCC) for breast cancer response to trastuzumab - Herceptin
by: Juranić Zorica D., et al.
Published: (2002-01-01)

How to improve the management of a patient with heparin-induced thrombocytopenia?
by: Anetta Undas
Published: (2019-11-01)

Trombocitopenia con trombosis inducida por heparina.
by: E Raez Luis
Published: (1996-07-01)

Direct Oral Anticoagulants as Successful Treatment of Heparin-Induced Thrombocytopenia: A Parisian Retrospective Case Series
by: Julie Carré, et al.
Published: (2021-08-01)

A case report of neonatal alloimmune thrombocytopenic purpura: the importance of correct diagnosis for future pregnancies
by: Rita Fontão-Wendel, et al.

THE HEPARIN INDUCED THROMBOCYTOPENIA IN CARDIAC SURGERY PATIENTS
by: Shakila Khadim, et al.
Published: (2020-12-01)

Prevalence of thrombocytopenia, anti–platelet factor 4 antibodies and D‐dimer elevation in Thai people After ChAdOx1 nCoV‐19 vaccination
by: Noppacharn Uaprasert, et al.
Published: (2021-08-01)

Heparin induced thrombocytopenia type ii and myocardial infarction: Two case reports
by: Antonijević Nebojša, et al.
Published: (2004-01-01)

Complete Penile Necrosis in a Patient With Heparin-induced Thrombocytopenia: A Case Report
by: Anne-Sophie Blais, et al.
Published: (2014-01-01)

Management of HER2-positive breast cancer: A review
by: S Viswanath, et al.
Published: (2016-01-01)

The Detection of Plasma Soluble Podoplanin of Patients with Breast Cancer and Its Clinical Signification
by: Zhu X, et al.
Published: (2020-12-01)

IS THE INCIDENCE TREND OF HEPARIN-INDUCED THROMBOCYTOPENIA DECREASED BY THE INCREASED USE OF LOW-MOLECULAR-WEIGHT-HEPARIN?
by: Fahad Al-Eidan
Published: (2015-04-01)